In yesterday’s Wall Street session, Teladoc Health Inc (NYSE:TDOC) shares traded at $9.70, down -1.12% from the previous session.
TDOC stock price is now 10.32% away from the 50-day moving average and -15.37% away from the 200-day moving average. The market capitalization of the company currently stands at $1.67B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $8 to $10, Jefferies maintained Hold rating for Teladoc Health Inc (NYSE: TDOC). On February 29, 2024, Cantor Fitzgerald recently initiated its ‘Overweight’ rating on the stock quoting a target price of $22, while ‘Leerink Partners’ rates the stock as ‘Market Perform’
In other news, Geshuri Arnnon, Former Officer bought 60,000 shares of the company’s stock on Nov 12 ’24. The stock was bought for $574,800 at an average price of $9.58. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 05 ’24, Officer Raman-Tangella Vidya bought 1,537 shares of the business’s stock. A total of $13,649 was incurred on buying the stock at an average price of $8.88. A total of 1.56% of the company’s stock is owned by insiders.
During the past 12 months, Teladoc Health Inc has had a low of $6.76 and a high of $22.54. As of last week, the company has a debt-to-equity ratio of 1.05, a current ratio of 1.69, and a quick ratio of 1.65. The fifty day moving average price for TDOC is $8.746 and a two-hundred day moving average price translates $11.5161 for the stock.
The latest earnings results from Teladoc Health Inc (NYSE: TDOC) was released for 2024-09-30. The net profit margin was -37.91% and return on equity was -51.65% for TDOC. The company reported revenue of $640.51 million for the quarter, compared to $660.24 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.99 percent.
